Figure 14From: Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of BrazilLevels of IgG1, IgG2, IgG3 and IgG4 antibodies against PvMSP-1 19 in malaria patients. * p = 0.04, IgG4 versus IgG1; p = 0.03, IgG4 versus IgG2; p = 0.01, IgG4 versus IgG3. Lines represent mean with standard deviation. Dotted line represents cut off.Back to article page